Active Shortage

TEVA-CHLOROQUINE

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEVA-CHLOROQUINE in Canada?

Yes. TEVA-CHLOROQUINE 250MG has an active shortage reported to Health Canada (last updated July 10, 2020).

Why is TEVA-CHLOROQUINE not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will TEVA-CHLOROQUINE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Affected strength250MG

Last updated2020-07-10

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ARALEN

SANOFI-SYNTHELABO CANADA INC

250MG · DIN 02017539

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

00021261

Strength

250MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CHLOROQUINE DIPHOSPHATE

Tier

Unrated

Last Updated

2020-07-10

Reason for Shortage

Shortage of an active ingredient.

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163